2bPrecise announced a new pharmacogenomics system as more and more vendors bring tools to market to bring precision medicine to physicians at the point of care.
Translational Software recently became the latest in a growing number of health IT vendors creating systems to advance precision medicine with its debut of its PGx pediatric platform. Another precision medicine player stepped into the market on Thursday with a product designed to be integrated smack dab in the middle of a physician’s clinical workflow. 2bPrecise, a cloud-based precision medicine platform vendor and an Allscripts company, launched a pharmacogenomics (PGx) system to bring crucial data to the clinical workflow.
A number of vendors have made moves in recent week. CureMatch announced its precision medicine system bested doctors at determining personalized cancer treatments. Neurotrack built a system that uses eye-tracking technology to predict and help prevent the development of Alzheimer’s. And Intermountain Precision Genomics is working with 10x Genomics to bring personalized medicine from the lab into clinical practice.
As more of these precision medicine tools come to market, the role of healthcare CIOs in precision medicine will gain prominence as these tools must be integrated into the clinical workflows of healthcare organizations.
2bPrecise PGx, for its part, makes pharmacogenetic information accessible so physicians can make better informed treatment decisions based on a patient’s unique genetic makeup.
2bPrecise has partnered with Translational Software, a genomic data-based clinical decision support system vendor, to leverage its knowledge base of PGx content.